디지털 치료제(DTx) 시장 예측(-2030년) : 오퍼링별, 매출 형태별, 판매채널별, 용도별, 지역별 세계 분석

According to Stratistics MRC, the Global Digital Therapeutics (DTx) Market is accounted for $10.99 billion in 2024 and is expected to reach $53.02 billion by 2030 growing at a CAGR of 30.0% during the forecast period. Digital therapeutics (DTx) are software-based interventions designed to prevent, manage, or treat medical conditions. Unlike traditional pharmaceuticals, DTx delivers therapeutic interventions through digital platforms such as mobile apps, wearables, or virtual reality. These interventions often leverage elements of cognitive behavioral therapy, mindfulness techniques, or personalized algorithms to address various health issues, including mental health disorders, chronic diseases, and substance abuse. DTx offers scalable, accessible, and cost-effective solutions, empowering individuals to take control of their health outside of traditional healthcare settings.

According to the 2022 report estimates published by the International Diabetes Federation (IDF) Diabetes Atlas, 62.0% of all new Type 1 Diabetes cases in 2022 were in people aged 20 years or older.

Market Dynamics:

Driver:

Rising healthcare costs

Rising healthcare costs serve as a major driver propelling the growth of the digital therapeutics (DTx) market. As traditional healthcare expenses continue to surge, there's a growing need for cost-effective and accessible solutions. DTx offers a promising alternative, leveraging technology to deliver evidence-based interventions for various medical conditions at a fraction of the cost of conventional treatments. With the potential to reduce healthcare expenditures through remote monitoring, personalized interventions, and improved patient outcomes, DTx are increasingly recognized as a vital component in the quest to curb escalating healthcare costs.

Restraint:

Data privacy and security concerns

Data privacy and security concerns in the digital therapeutics (DTx) market revolve around safeguarding sensitive patient information and ensuring the integrity of treatment data. With the collection and analysis of personal health data, there's a heightened risk of breaches, leading to potential exploitation or identity theft. Moreover, maintaining confidentiality is crucial to building trust between patients and DTx providers. Security measures must be robust to prevent unauthorized access, tampering, or leaks of health data, ensuring compliance with regulations like HIPAA (Health Insurance Portability and Accountability Act) in the U.S. and GDPR (General Data Protection Regulation) in the European Union.

Opportunity:

Integration with wearable devices and sensors

Integration with wearable devices and sensors presents a significant opportunity in the digital therapeutics (DTx) market by enhancing real-time monitoring and personalized treatment delivery. By connecting with wearables like smartwatches and fitness trackers, DTx platforms can gather continuous biometric data, enabling more accurate health insights and treatment adjustments. This integration facilitates remote patient monitoring, allowing healthcare providers to intervene proactively and tailor interventions to individual patients needs. Wearable integration promotes patient engagement and adherence by offering a seamless user experience and real-time feedback.

Threat:

Health inequities and access

The emergence of digital therapeutics (DTx) holds promise for revolutionizing healthcare delivery by offering convenient, accessible, and personalized treatments. However, there's a looming concern regarding health inequities and access within this burgeoning market. While DTx has the potential to reach a wide audience, including underserved communities, disparities may arise due to factors like technological literacy, access to smartphones or internet connectivity, and socioeconomic status.

Covid-19 Impact:

The COVID-19 pandemic has significantly accelerated the adoption of digital therapeutics (DTx) as people seek remote healthcare solutions. With lockdowns and social distancing measures in place, there was a surge in demand for virtual healthcare services, including digital therapeutics. The pandemic highlighted the need for accessible and convenient healthcare options, leading to increased investment and innovation in the DTX market. Telemedicine platforms integrating digital therapeutics saw a rapid uptake, offering personalized treatment plans for chronic conditions like diabetes, mental health disorders, and hypertension.

The software/platforms segment is expected to be the largest during the forecast period

The software/platforms segment in the digital therapeutics (DTx) market has experienced robust growth due to several key factors. The increasing adoption of digital health solutions and wearable devices has propelled demand for software platforms that facilitate the delivery of DTx interventions. Additionally, advancements in technology, such as artificial intelligence and machine learning algorithms, have enabled the development of more sophisticated and personalized digital therapeutic solutions. Furthermore, the emphasis on preventive healthcare and the rising prevalence of chronic diseases have fueled the demand for digital therapeutics.

The treatment/care-related applications segment is expected to have the highest CAGR during the forecast period

The Treatment/Care-related Applications segment in the Digital Therapeutics (DTx) market has witnessed substantial growth due to the increasing prevalence of chronic diseases like diabetes, hypertension, and obesity has amplified the demand for remote monitoring and management solutions, which this segment provides. Advancements in technology, particularly in wearables and mobile health apps, have made it easier to track patient progress and deliver personalized interventions. Additionally, the rising adoption of telemedicine and virtual care models has further propelled the expansion of treatment- and care-related DTx applications.

Region with largest share:

The growth of the laser processing market in North America can be attributed to several key factors. Technological advancements have led to the development of more efficient and precise laser processing systems, increasing their adoption across various industries, including automotive, electronics, and healthcare. The region's robust manufacturing sector, particularly in the United States, has fueled demand for laser processing solutions for applications such as cutting, welding, and marking. Additionally, the rising emphasis on automation and productivity enhancement in industries has further propelled the uptake of laser processing technologies. Moreover, increasing investments in research and development activities aimed at enhancing laser processing capabilities have also contributed to market growth in the region.

Region with highest CAGR:

The Asia-Pacific region's laser processing market has witnessed substantial growth due to several factors. The region's burgeoning manufacturing sector, particularly in countries like China, Japan, and South Korea, has driven the demand for laser processing technologies across various industries such as automotive, electronics, and healthcare. Additionally, advancements in laser technology, including improved precision and efficiency, have fuelled adoption rates. Increasing investments in research and development by key market players and government initiatives promoting technological innovation have further propelled market expansion.

Key players in the market

Some of the key players in Digital Therapeutics (DTx) market include Akili Interactive Labs, Biofourmis, Inc., Brain+ A/S, CureApp, Inc., DarioHealth, Fitbit Health Solutions, Gaia AG, Lark Health, LifeScan, Inc., Omada Health Inc, Otsuka Holdings Co., Ltd., Pear Therapeutics Inc, ResMed, Teladoc Health, Virta Health Corp and WellDoc, Inc.

Key Developments:

In June 2024, Google recently introduced Fitbit Ace LTE - "a new, first-of-its-kind connected smartwatch for kids ages 7+. Ace LTE transforms exercise into play, while also giving families peace of mind with reliable calling, messaging and location sharing with parents." The company's VP of Product, Anil Sabharwal, said in a blog post.

In March 2024, Digital health company Welldoc has secured CE mark certification for its BlueStar mobile app, unlocking the advancement of its solutions in Europe. The app has been certified as a Class IIa medical device under the EU Medical Device Regulation.

Offerings Covered:

• Programs
• Software/Platforms
• Virtual Reality/Games

Revenue Modals Covered:

• Outcome/Value based
• Subscription
• One time Purchase/Licensing

Sales Channels Covered:

• Business to Customer
• Business to Business

Applications Covered:

• Preventive Applications
• Treatment/Care-related Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Digital Therapeutics (DTx) Market, By Offering

• 5.1 Introduction
• 5.2 Programs
• 5.3 Software/Platforms
• 5.4 Virtual Reality/Games

6 Global Digital Therapeutics (DTx) Market, By Revenue Modal

• 6.1 Introduction
• 6.2 Outcome/Value based
• 6.3 Subscription
• 6.4 One time Purchase/Licensing

7 Global Digital Therapeutics (DTx) Market, By Sales Channel

• 7.1 Introduction
• 7.2 Business to Customer
  • 7.2.1 Patients
  • 7.2.2 Caregivers
• 7.3 Business to Business
  • 7.3.1 Payers
  • 7.3.2 Employers
  • 7.3.3 Pharmaceutical Companies
  • 7.3.4 Providers

8 Global Digital Therapeutics (DTx) Market, By Application

• 8.1 Introduction
• 8.2 Preventive Applications
  • 8.2.1 Prediabetes
  • 8.2.2 Obesity
  • 8.2.3 Nutrition
  • 8.2.4 Lifestyle Management
  • 8.2.5 Other Preventive Applications
• 8.3 Treatment/Care-related Applications
  • 8.3.1 Diabetes
  • 8.3.2 Central nervous system Disorders
  • 8.3.3 Mental Health Disorder
  • 8.3.4 Chronic Respiratory Disorders
  • 8.3.5 Musculoskeletal Disorders
  • 8.3.6 Cardiovascular Diseases
  • 8.3.7 Smoking Cessation
  • 8.3.8 Medication Adherence
  • 8.3.9 Gastrointestinal Disorders
  • 8.3.10 Substance Use & Addiction Management
  • 8.3.11 Rehabilitation & Patient Care
  • 8.3.12 Insomnia
  • 8.3.13 Hypertension
  • 8.3.14 Other Treatment/Care-related Applications

9 Global Digital Therapeutics (DTx) Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Akili Interactive Labs
• 11.2 Biofourmis, Inc.
• 11.3 Brain+ A/S
• 11.4 CureApp, Inc.
• 11.5 DarioHealth
• 11.6 Fitbit Health Solutions
• 11.7 Gaia AG
• 11.8 Lark Health
• 11.9 LifeScan, Inc.
• 11.10 Omada Health Inc
• 11.11 Otsuka Holdings Co., Ltd.
• 11.12 Pear Therapeutics Inc
• 11.13 ResMed
• 11.14 Teladoc Health
• 11.15 Virta Health Corp
• 11.16 WellDoc, Inc.